Form 4 for ARVN ARVINAS, INC.

Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001655759-24-000026 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-02-27	2024-02-23	ARVN	Peck Ronald	Chief Medical Off	A - Grant	$0.00	+39.2K	69.2K	+131%	$0
D	2024-02-27	2024-02-23	ARVN	Peck Ronald	Chief Medical Off	S - Sale	$47.05	-1,699	67.5K	-2%	-$79.9K
D	2024-02-27	2024-02-23	ARVN	Peck Ronald	Chief Medical Off	A - Grant	$0.00	+58.1K	58.1K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-23	A	A	39,250	$0.00	69,215	D	—	—	(F1) The restricted stock units (each, an "RSU") were granted by the Issuer on February 23, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.
2	Common	Common Stock	2024-02-23	S	D	1,699	$47.05	67,516	D	—	—	(F2) This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
3	Derivative	Stock Option (right to buy)	2024-02-23	A	A	58,100	$0.00	58,100	D	$47.00 · — to 2034-02-22	58,100 Common Stock	(F3) The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on February 23, 2025, with the remainder of the shares vesting on February 23, 2026.